Glaxosmithkline

We track 3 ClinicalTrials.gov studies led by Glaxosmithkline. The portfolio skews toward Phase 2 (2 trials).

3 clinical trials sponsored by Glaxosmithkline.

Pipeline by Phase

Phase	Trials	Distribution
Phase 2	2	67%
Phase 1	1	33%

Trial Status Breakdown

RECRUITING: 2 trials
TERMINATED: 1 trial

Trials by Glaxosmithkline

A Phase 1, Open-label, Dose-escalation Study (ELEVATE-1) to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of a CD19/CD20 T-cell Engager in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)

NCT07371468 · RECRUITING · Phase 1

A Multi-Centre, Single Arm, Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of GSK4527226 (AL101) in Participants With Early Alzheimer's Disease

NCT07105709 · RECRUITING · Phase 2

A Phase I/II, Open-Label Study to Investigate the Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics of GSK3145095 Administered Alone and in Combination With Anticancer Agents Including Pembrolizumab in Adult Participants With Selected Advanced Solid Tumors

NCT03681951 · TERMINATED · Phase 2

Frequently Asked Questions

How many clinical trials does Glaxosmithkline sponsor?

Glaxosmithkline currently sponsors 3 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 1.

What conditions does Glaxosmithkline research?

Glaxosmithkline conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Glaxosmithkline recruiting for clinical trials?

Yes, Glaxosmithkline currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.